# Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection

Study · id `cardio:ct-nct02651428` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02651428](<https://clinicaltrials.gov/study/NCT02651428>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02651428

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 806 participants.

## Technical summary

Registry record NCT02651428. Randomized; triple masking; primary purpose prevention. Start 2015-12 (registry gives no type); primary completion 2018-10 (actual). Results posted on 2021-08-31.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 806 participants (enrolled count; ClinicalTrials.gov record NCT02651428, source copy `cardio:ctgov-nct02651428-2025-02-25`, retrieved 2026-10-26)
- Start date: 2015-12 (registry gives no type) (ClinicalTrials.gov record NCT02651428, source copy `cardio:ctgov-nct02651428-2025-02-25`, retrieved 2026-10-26)
- Primary completion: 2018-10 (actual) (ClinicalTrials.gov record NCT02651428, source copy `cardio:ctgov-nct02651428-2025-02-25`, retrieved 2026-10-26)
- Completion: 2018-10 (actual) (ClinicalTrials.gov record NCT02651428, source copy `cardio:ctgov-nct02651428-2025-02-25`, retrieved 2026-10-26)
- Results first posted: 2021-08-31 (ClinicalTrials.gov record NCT02651428, source copy `cardio:ctgov-nct02651428-2025-02-25`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02651428, source copy `cardio:ctgov-nct02651428-2025-02-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02651428-2025-02-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection
- Condition: Kidney Failure, Chronic
- Condition: Catheter-Related Infections
- Intervention (Drug): Neutrolin
- Intervention (Drug): Heparin
- Lead sponsor: CorMedix Therapeutics
- Lead sponsor class: INDUSTRY
- Collaborator: PPD Development, LP
- Collaborator class: INDUSTRY
- Collaborator: JMI Laboratories
- Collaborator class: INDUSTRY
- Collaborator: Spectra Clinical Research
- Collaborator class: OTHER
- Collaborator: Davita Clinical Research
- Collaborator class: INDUSTRY
- Collaborator: Frenova Renal Research
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry intervention name matches this record: Heparin (`cardio:heparin`)
- Registry lists this organization as a collaborator: PPD Development, LP (`cardio:org-ppd-development-lp`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Taurolidine/Heparin Lock Solution and Catheter-Related Bloodstream Infection in Hemodialysis: A Randomized, Double-Blind, Active-Control, Phase 3 Study (`cardio:pubmed-37678222`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 3d19ce874dc7c18da9ef382157cecb83e821210c4dfd04254263a7c916871b97
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
